Here, we examined the prognostic and treatment predictive value of SATB2 expression in a large number (n=527) of CRC cases from a prospective population-based cohort study (Larsson et al, 2011; Wangefjord et al, 2011). This evidence concerns the gene SATB2 and colorectal carcinoma.